100.2400.15% ( -0.150 )
Closed: Oct 21, 16:00:00 (EDT)Current ValuationThe current P/E ratio is 23.77, within the reasonable range, cheaper than 51.34% of the time in the past 1 years, and the industry ranks 8/44, the industry Median -0.40.
23.77xP/E
$100.24Stock price
$4.22Earnings per share
23.77xP/E
Stock price$100.24Earnings per share$4.22
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 23.78x
- Typical range
- 22.07x–25.80x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
017345168
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
| Name/Symbol | |||
|---|---|---|---|
ALGNUSAlign | 26.00x | 25.56% | $10.75B |
LNTHUSLantheus | 23.77x | 38.32% | $6.54B |
BVSUSBioventus | 21.99x | 134.55% | $1.20B |
ACUUSAcme Utd | 24.69x | 6.02% | $242.30M |
UTMDUSUtah Medical Products | 22.68x | -- | $237.89M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
